300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
CleanTech
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Art
Publishing
Real Estate
Sporting Goods
Manufacturing
Mobile Apps
FinTech
Finance
Digital Media
Wine and Spirits
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Enterprise
Hardware
Community
Biotech
Transportation
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Barbados
Belgium
Jordan
Angola
Ethiopia
Cyprus
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bahrain
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Liechtenstein
Lithuania
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Happiness Capital, VC Fund

Happiness Capital

VC Fund

Hong Kong, Hong Kong

Happiness Capital is a venture capital firm that invests in startups that aim to improve the world’s happiness. The firm helps entrepreneurs to co-create a happier world as a global community. Its investment portfolio covers seed to growth-stage companies in the US, Europe, Israel, China, and Hong Kong, with the focus on the future of food, health,education, and work.Happiness Capital was founded in 2017 and is headquartered in Hong Kong.

Total investments:
42
Last investment:
Lead investor:
36%

Last updated:

Industries Happiness Capital invests in

BiotechnologyFood and BeverageHealth CareLife ScienceAgTech

Stages Happiness Capital invests in

Series ASeedSeries BVenture - Series UnknownSeries C

Countries Happiness Capital invests in

United StatesGermanyUnited KingdomIsraelChina

Round sizes

Seed $2.2M–$9.3MSeries A $10M–$45MSeries B $8.7M–$61M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$2.2M–$9.3M
Series A
$10M–$45M
Series B
$8.7M–$61M

Investment Focus

Industry

  • Biotechnology 13 (31%)
  • Food and Beverage 7 (17%)
  • Health Care 5 (12%)
  • Life Science 5 (12%)
  • AgTech 3 (7%)
See all 56 industries →

Stage

  • Series A 13 (31%)
  • Seed 11 (26%)
  • Series B 5 (12%)
  • Venture - Series Unknown 3 (7%)
  • Series C 2 (5%)
See all 8 stages →

Country

  • United States 11 (26%)
  • Germany 8 (19%)
  • United Kingdom 4 (10%)
  • Israel 2 (5%)
  • China 1 (2%)
See all 9 countries →

Team

NameTitleInvestmentsLinksEmail
Allan Chan
Allan Chan Executive Director
Executive Director Total investments: 0 Find email
Eric Ng
Eric Ng Managing Director & CEO
Managing Director & CEO Total investments: 9
Find email
Mark Chan
Mark Chan VP, Investment
VP, Investment Total investments: 0
Find email
Sammy Lee
Sammy Lee Chief Invisible Officer
Chief Invisible Officer Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
We make aging beautiful. Voxela improves QOL and profitability of those eldercare businesses for a sustainable society. Series A / Sep 16, 2026
heXem bio specializes in recording solutions for the early development of humans for longevity. Seed / Sep 15, 2026
Mellizyme Biotechnology is currently operating in stealth. $12M / Venture - Series Unknown / Mar 25, 2026
Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts. Series D / Aug 21, 2025
Mellizyme Biotechnology is currently operating in stealth. $18.3M / Series A / Mar 05, 2025
Project Eaden combines pioneering technology with an immense love for life and food. $15.6M / Series A / Jan 22, 2025
Formo is Europe’s first cellular agriculture company developing animal-free dairy products using real, nature-identical milk proteins derived from precision fermentation. $61M / Series B / Sep 09, 2024
NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems. $18M / Series A / Jul 09, 2024
Xias Bio is a biotechnology startup specializing in the production of recombinant proteins, offering formulators advanced soluble, active ingredients with improved attributes such as enhanced gel and film formation, as well as antioxidant properties. The company creates non-immunogenic natural motifs to produce a better delivery platform offunctionalities for research, beauty, and healthcare. $4.8M / Seed / May 01, 2024
Infinite Roots is a technology-driven company that harnesses natural ingredients to create sustainable health and wellness products. They emphasize using organic and ethically sourced materials, blending traditional remedies with modern science to promote holistic well-being. Infinite Roots offers a range of products, including herbal supplements,skincare, and wellness solutions, all aimed at supporting natural healing and balance. They aim to create eco-friendly, effective products while maintaining a deep commitment to environmental sustainability and ethical practices. $57.5M / Series B / Jan 25, 2024
See all 42 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
CleanTech
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Art
Publishing
Real Estate
Sporting Goods
Manufacturing
Mobile Apps
FinTech
Finance
Digital Media
Wine and Spirits
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Enterprise
Hardware
Community
Biotech
Transportation
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Gibraltar
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Qatar
Barbados
Belgium
Jordan
Angola
Ethiopia
Cyprus
Austria
Azerbaijan
Bulgaria
Faroe Islands
Ecuador
Jersey
Bahrain
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Liechtenstein
Lithuania
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Happiness Capital invest in?

Happiness Capital invests primarily in Biotechnology, Food and Beverage and Health Care startups, most often at Series A and Seed stage. Most of the 42 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Happiness Capital's check size?

Happiness Capital typically joins rounds of $2.2M–$9.3M at Seed, $10M–$45M at Series A and $8.7M–$61M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Happiness Capital participates in.

How do I contact Happiness Capital?

Public channels for Happiness Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Happiness Capital?

The team at Happiness Capital includes Allan Chan (Executive Director), Eric Ng (Managing Director & CEO) and Mark Chan (VP, Investment). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Happiness Capital Happiness Capital Find emails